日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Analysis of on-treatment cancer safety events with daprodustat versus conventional erythropoiesis-stimulating agents-post hoc analyses of the ASCEND-ND and ASCEND-D trials

达普司他与传统促红细胞生成剂治疗期间癌症安全性事件分析——ASCEND-ND 和 ASCEND-D 试验的事后分析

Singh, Ajay K; McCausland, Finnian R; Claggett, Brian L; Wanner, Christoph; Wiecek, Andrzej; Atkins, Michael B; Carroll, Kevin; Perkovic, Vlado; McMurray, John J V; Wittes, Janet; Snapinn, Steven; Blackorby, Allison; Meadowcroft, Amy; Barker, Tara; DiMino, Tara; Mallett, Stephen; Cobitz, Alexander R; Solomon, Scott D

Regional Variation of Erythropoiesis-Stimulating Agent Hyporesponsiveness in the Global Daprodustat Dialysis Study (ASCEND-D)

全球达普司他透析研究(ASCEND-D)中促红细胞生成素低反应性的区域差异

Macdougall, Iain C; Meadowcroft, Amy M; Blackorby, Allison; Cizman, Borut; Cobitz, Alexander R; Godoy, Sergio; Jha, Vivekanand; Johansen, Kirsten L; McMahon, Gearoid; Obrador, Gregorio T; Wong, Muh Geot; Singh, Ajay K

Efficacy and Safety of Daprodustat for Treatment of Anemia of Chronic Kidney Disease in Incident Dialysis Patients: A Randomized Clinical Trial

达普司他治疗新发透析患者慢性肾脏病贫血的疗效和安全性:一项随机临床试验

Singh, Ajay K; Cizman, Borut; Carroll, Kevin; McMurray, John J V; Perkovic, Vlado; Jha, Vivekanand; Johansen, Kirsten L; Lopes, Renato D; Macdougall, Iain C; Obrador, Gregorio T; Waikar, Sushrut S; Wanner, Christoph; Wheeler, David C; Wiecek, Andrzej; Stankus, Nicole; Strutz, Frank; Blackorby, Allison; Cobitz, Alexander R; Meadowcroft, Amy M; Paul, Gitanjali; Ranganathan, Prerna; Sedani, Sangeeta; Solomon, Scott

Three Times Weekly Dosing of Daprodustat versus Conventional Epoetin for Treatment of Anemia in Hemodialysis Patients: ASCEND-TD: A Phase 3 Randomized, Double-Blind, Noninferiority Trial

达普司他每周三次给药与传统促红素治疗血液透析患者贫血的疗效比较:ASCEND-TD:一项3期随机、双盲、非劣效性试验

Coyne, Daniel W; Singh, Ajay K; Lopes, Renato D; Bailey, Christine K; DiMino, Tara L; Huang, Chun; Connaire, Jeffrey; Rastogi, Anjay; Kim, Sung-Gyun; Orias, Marcelo; Shah, Sapna; Patel, Vickas; Cobitz, Alexander R; Wanner, Christoph

Study design and baseline characteristics of patients on dialysis in the ASCEND-D trial

ASCEND-D试验的研究设计和透析患者的基线特征

Singh, Ajay K; Blackorby, Allison; Cizman, Borut; Carroll, Kevin; Cobitz, Alexander R; Davies, Rich; Jha, Vivekanand; Johansen, Kirsten L; Lopes, Renato D; Kler, Lata; Macdougall, Iain C; McMurray, John J V; Meadowcroft, Amy M; Obrador, Gregorio T; Perkovic, Vlado; Solomon, Scott; Wanner, Christoph; Waikar, Sushrut S; Wheeler, David C; Wiecek, Andrzej

The ASCEND-ND trial: study design and participant characteristics

ASCEND-ND试验:研究设计和参与者特征

Perkovic, Vlado; Blackorby, Allison; Cizman, Borut; Carroll, Kevin; Cobitz, Alexander R; Davies, Rich; DiMino, Tara L; Jha, Vivekanand; Johansen, Kirsten L; Lopes, Renato D; Kler, Lata; Macdougall, Iain C; McMurray, John J V; Meadowcroft, Amy M; Obrador, Gregorio T; Solomon, Scott; Taft, Lin; Wanner, Christoph; Waikar, Sushrut S; Wheeler, David C; Wiecek, Andrzej; Singh, Ajay K

Challenges of Conducting Clinical Trials during the SARS-CoV-2 Pandemic: The ASCEND Global Program Experience

在 SARS-CoV-2 大流行期间开展临床试验的挑战:ASCEND 全球项目的经验

Johansen, Kirsten L; Acharya, Anjali; Cizman, Borut; Cobitz, Alexander R; Correa-Rotter, Ricardo; Dasgupta, Indranil; Kher, Vijay; Lopes, Renato D; Matsumoto, Leonardo; Meadowcroft, Amy M; Merege Vieira Neto, Osvaldo; Okabe, Marilu; Rayner, Brian; Silva, Arnold; Thomas, Hilary; Singh, Ajay K

Pharmacokinetics of Daprodustat and Metabolites in Individuals with Normal and Impaired Hepatic Function

肝功能正常和受损个体中 Daprodustat 及其代谢物的药代动力学

Kelly M Mahar, Bonnie C Shaddinger, Bandi Ramanjineyulu, Susan Andrews, Stephen Caltabiano, Alistair C Lindsay, Alexander R Cobitz

Safety of daprodustat in patients with anemia of chronic kidney disease: A pooled analysis of phase 3 studies in Japan

达普司他治疗慢性肾脏病贫血患者的安全性:日本3期研究的汇总分析

Nangaku, Masaomi; Akizawa, Tadao; Nagakubo, Takashi; Yonekawa, Taeko; Kimura, Toshifumi; Endo, Yukihiro; Cobitz, Alexander

Daprodustat Compared with Epoetin Beta Pegol for Anemia in Japanese Patients Not on Dialysis: A 52-Week Randomized Open-Label Phase 3 Trial

达普司他与促红素β-聚乙二醇治疗日本非透析患者贫血的比较:一项为期52周的随机开放标签3期试验

Nangaku, Masaomi; Hamano, Takayuki; Akizawa, Tadao; Tsubakihara, Yoshiharu; Nagai, Reiko; Okuda, Nobuhiko; Kurata, Kyo; Nagakubo, Takashi; Jones, Nigel P; Endo, Yukihiro; Cobitz, Alexander R